Tan Edwin S, Naylor John C, Groban Eli S, Bunzow James R, Jacobson Matthew P, Grandy David K, Scanlan Thomas S
Chemistry and Chemical Biology Graduate Program, University of California, San Francisco, San Francisco, California 94158, USA.
ACS Chem Biol. 2009 Mar 20;4(3):209-20. doi: 10.1021/cb800304d.
The trace amine-associated receptor 1 (TAAR(1)) is an aminergic G protein-coupled receptor (GPCR) potently activated by 3-iodothyronamine (1), an endogenous derivative of thyroid hormone. Structure-activity relationship studies on 1 and related agonists showed that the rat and mouse species of TAAR(1) accommodated structural modifications and functional groups on the ethylamine portion and the biaryl ether moiety of the molecule. However, the two receptors clearly exhibited distinct, species-specific ligand preferences despite being remarkably similar with 93% sequence similarity. In this study, we generated single and double mutants of rat and mouse TAAR(1) to probe the molecular recognition of agonists and the underlying basis for the ligand selectivity of rat and mouse TAAR(1). Key, nonconserved specificity determinant residues in transmembranes helices 4 and 7 within the ligand binding site appear to be the primary source of a number of the observed ligand preferences. Residue 7.39 in transmembrane 7 dictated the preference for a beta-phenyl ring, while residue 4.56 in transmembrane 4 was partially responsible for the lower potency of 1 and tyramine for the mouse receptor. Additionally, 1 and tyramine were found to have the same binding mode in rat TAAR(1) despite structure-activity relationship data suggesting the possibility of each molecule having different binding orientations. These findings provide valuable insights into the critical binding site residues involved in the ligand-receptor interaction that can influence compound selectivity and functional activity of aminergic GPCRs.
痕量胺相关受体1(TAAR(1))是一种胺能G蛋白偶联受体(GPCR),可被甲状腺激素的内源性衍生物3-碘甲腺原氨酸(1)有效激活。对1及相关激动剂的构效关系研究表明,TAAR(1)的大鼠和小鼠亚型能够容纳分子乙胺部分和联芳基醚部分的结构修饰和官能团。然而,尽管两种受体的序列相似度高达93%,但它们明显表现出不同的物种特异性配体偏好。在本研究中,我们构建了大鼠和小鼠TAAR(1)的单突变体和双突变体,以探究激动剂的分子识别以及大鼠和小鼠TAAR(1)配体选择性的潜在基础。配体结合位点内跨膜螺旋4和7中的关键非保守特异性决定残基似乎是许多观察到的配体偏好的主要来源。跨膜7中的残基7.39决定了对β-苯环的偏好,而跨膜4中的残基4.56部分导致了1和酪胺对小鼠受体的效力较低。此外,尽管构效关系数据表明每个分子可能具有不同的结合方向,但发现1和酪胺在大鼠TAAR(1)中具有相同的结合模式。这些发现为参与配体-受体相互作用的关键结合位点残基提供了有价值的见解,这些残基可影响胺能GPCR的化合物选择性和功能活性。